Clearside Biomedical, Inc. (CLSD)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 91.94M |
| Enterprise Value | 63.44M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.99 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 8.43 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.35 |
| 52-Week Change 3 | 44.88% |
| S&P500 52-Week Change 3 | 26.33% |
| 52 Week High 3 | 2.1200 |
| 52 Week Low 3 | 0.6500 |
| 50-Day Moving Average 3 | 1.1105 |
| 200-Day Moving Average 3 | 1.2634 |
Share Statistics
| Avg Vol (3 month) 3 | 242.57k |
| Avg Vol (10 day) 3 | 460.78k |
| Shares Outstanding 5 | 74.75M |
| Implied Shares Outstanding 6 | 74.75M |
| Float 8 | 69.14M |
| % Held by Insiders 1 | 7.42% |
| % Held by Institutions 1 | 26.33% |
| Shares Short (Aug 30, 2024) 4 | 335.17k |
| Short Ratio (Aug 30, 2024) 4 | 1.48 |
| Short % of Float (Aug 30, 2024) 4 | 0.48% |
| Short % of Shares Outstanding (Aug 30, 2024) 4 | 0.45% |
| Shares Short (prior month Jul 31, 2024) 4 | 206.86k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -8,433.33% |
Management Effectiveness
| Return on Assets (ttm) | -44.05% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 7.52M |
| Revenue Per Share (ttm) | 0.11 |
| Quarterly Revenue Growth (yoy) | -91.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | -25.66M |
| Net Income Avi to Common (ttm) | -33.46M |
| Diluted EPS (ttm) | -0.5000 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 29.36M |
| Total Cash Per Share (mrq) | 0.39 |
| Total Debt (mrq) | 47.59M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.07 |
| Book Value Per Share (mrq) | -0.38 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19.11M |
| Levered Free Cash Flow (ttm) | -17.5M |
© 2024 Yahoo. All rights reserved.